Summary of Previous Meeting
Click here for ECCR 2011 Final Programme and Abstract Book
Click here for Speakers
Presentations
 Introduction
The 16th Annual Meeting of the European
Council for Cardiovascular Research (ECCR) took
place in La Colle sur Loup, near Nice, France,
from 30th September – 2nd October 2011.
Over 190 participants represented the major
research active groups in Europe and contributed
to a programme noted for its outstanding
scientific quality.
Members of the Council, presenters of
critically refereed communications and a number
of keynote lecturers contributed to a widely
varying programme of topics.
 Keynote
Lectures were given on the subjects of ‘Microparticles
in cardiovascular disease’ (Chantal Boulanger,
Paris), 'Gene variants in the prediction of
hypertension' (Giuseppe Bianchi, Milan) and
a special lecture on 'Changes of vascular
structure and function - consequences for CV
risk' (Johannes Baulmann, Lübeck).
Abstracts
Abstracts are available to view by clicking on
the link at the top of the page.
ECCR Prizes
The prize for the Best Oral Presentation on
Friday went to Veronica Velero-Esquitino for her
presentation entitled ‘Direct AT2-receptor
stimulation protects from demyelination and
promotes remyelination in an in vitro model of
neuroinflammation.’
The prize for the Best Oral Presentation on
Saturday went to Ties Mulders for his
presentation entitled ‘Asymptomatic subjects
with a positive family history for premature
cardiovascular disease and high calcium scores
benefit from treatment: a sub-analysis from the
St. Francis Heart Study Randomized Clinical
Trial.’
The prize for the best Young Investigator
Presentation went to Jeppe Grondahl Rasmussen
for his presentation entitled ‘In human adipose
tissue-derived stem cells protease-activated
receptor 2 activation induces VEGF without
stabilization of HIF-1α.’
Corporate Members
The ECCR Executive Committee would like to
acknowledge the assistance of the following
companies who participated in the ECCR this
year, therefore helping to improve coordination of
research in Europe:
|
Principal Sponsor: |
German Institute for High Blood
Pressure Research (DIB) |
|
Major Sponsor: |
AstraZeneca |
Sponsors:
|
Actelion Pharmaceuticals Ltd
Apeiron Biologics AG
I.E.M. GmbH
Servier |
|
Supporters: |
Daiichi Sankyo |
|
|
DMT A/S |
| |
SMT Medical GmbH
& Co |
In 2012, the ECCR will have two major
activities: (1) contribution to Frontiers in
Cardiovascular Biology (FCVB), London, March
2012: (2) contribution to 24th Meeting of the
International Society of Hypertension, Sydney,
29 Sept - 4 Oct 2012. The Annual meeting in Nice
will return in 2013.
Michael Mulvany
President, ECCR
|
